Allena Pharmaceuticals Completes $53M Series C Financing
Allena Pharmaceuticals, Inc., a Newton, MA-based biopharmaceutical company focused on developing and commercializing innovative non-systemic oral protein therapeutics to treat metabolic and orphan diseases, completed a $53m Series C financing. The round was led by Partner Fund Management with participation…